1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. CLINICAL CRO MARKET BY CLINICAL PHASE
4.1. Introduction
4.2. Phase I Trials
4.3. Phase II Trials
4.4. Phase III Trials
4.5. Phase IV (Post-Marketing Surveillance)
5. CLINICAL CRO MARKET BY THERAPEUTIC AREA
5.1. Introduction
5.2. Oncology
5.3. CNS
5.4. Cardiovascular
5.5. Infectious Diseases
5.6. Immunology
5.7. Metabolic Disorders
5.8. Rare Diseases
5.9. Others (Gene or Cell therapies, autoimmune, respiratory diseases, etc.)
6. CLINICAL CRO MARKET BY SERVICE CATEGORY
6.1. Introduction
6.2. Clinical Operations and Monitoring
6.3. Data and Analytics
6.4. Regulatory and Safety
6.5. Real-World Evidence (RWE) & Health Economics Outcomes Research (HEOR)
7. CLINICAL CRO MARKET BY CLIENT TYPE
7.1. Introduction
7.2. Large Pharma
7.3. Small & Mid Biotech
7.4. Medical Device Companies
7.5. Government and Academic Institutes
7.6. CDMOs
8. CLINICAL CRO MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. United Kingdom
8.4.2. France
8.4.3. Germany
8.4.4. Spain
8.4.5. Italy
8.4.6. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Israel
8.5.4. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. Japan
8.6.3. India
8.6.4. South Korea
8.6.5. Taiwan
8.6.6. Thailand
8.6.7. Indonesia
8.6.8. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Emerging Players and Market Lucrativeness
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. IQVIA Holdings Inc.
10.2. Thermo Fisher Scientific Inc. (PPD)
10.3. ICON plc
10.4. Laboratory Corporation of America Holdings
10.5. Syneos Health, Inc.
10.6. Parexel International Corporation
10.7. Charles River Laboratories International, Inc.
10.8. Medpace Holdings, Inc.
10.9. WuXi AppTec Co., Ltd.
10.10. Fortrea Holdings Inc.
10.11. Novotech Pty Ltd.
10.12. PSI CRO AG
10.13. Medidata Solutions, Inc.